Publication | Closed Access

Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in children in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial

VaccinationVaccine SafetyVaccine DevelopmentImmunologyEbola VaccineChimpanzee AdenovirusInfection ControlMedicineVaccine ResearchEpidemiology